OverviewChartNewsTraderScreen

BNP Paribas Discount Zert PFE 29..../  DE000PC1SQ65  /

EUWAX
6/5/2024  8:54:29 AM Chg.+0.25 Bid3:08:35 PM Ask3:08:35 PM Underlying Strike price Expiration date Option type
23.15EUR +1.09% 23.14
Bid Size: 8,000		 23.19
Ask Size: 8,000		 Pfizer Inc - USD 12/29/2025 Call
GlobeNewswire 2:00 PM Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
GlobeNewswire 7:00 AM Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Co...
GlobeNewswire 6/4 Alation Deepens Integration with Snowflake to Improve Data Quality and Deliver AI-Ready Data
GlobeNewswire 6/4 Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
GlobeNewswire 6/3 Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire 5/16 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...
TeleTrader 5/1 Pfizer's Q1 revenue drops 20% to $14.9 billion
GlobeNewswire 4/30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...
GlobeNewswire 3/22 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...
GlobeNewswire 3/20 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire 3/7 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...
GlobeNewswire 3/7 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...
GlobeNewswire 3/5 LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd...
GlobeNewswire 2/28 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...
GlobeNewswire 2/28 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...
GlobeNewswire 2/27 Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment t...
GlobeNewswire 2/23 Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
GlobeNewswire 2/20 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...
GlobeNewswire 2/16 ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Befo...
GlobeNewswire 2/11 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...
GlobeNewswire 2/8 ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Importan...
GlobeNewswire 2/6 Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment o...
GlobeNewswire 2/3 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTe...
TeleTrader 1/30 Pfizer posts Q4 revenue of $14B, reaffirms guidance
GlobeNewswire 1/26 ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadl...